DIFFERENTIAL BINDING OF AGONISTS AND ANTAGONISTS TO GABA RECEPTOR POPULATIONS

被引：0

作者：

MAKSAY, G ^{[1
]}

TICKU, MK ^{[1
]}

机构：

[1] UNIV TEXAS,HLTH SCI CTR,DEPT PHARMACOL,SAN ANTONIO,TX 78284

来源：

FEDERATION PROCEEDINGS | 1984年 / 43卷 / 03期

关键词：

D O I：

暂无

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：286 / 286

页数：1

共 50 条

[41] EFFECTS OF GABA, OPIATE AND DA RECEPTOR AGONISTS AND ANTAGONISTS IN THE ETHANOL-WITHDRAWN MOUSE
URWYLER, S
BLACK, R
TABAKOFF, B
BRAIN RESEARCH BULLETIN, 1979, 4 (05) : 692 - 692
[42] A photoreactive probe that differentiates the binding sites of noncompetitive GABA receptor antagonists
Shimotahira, Hiroshi
Fusazaki, Sayaka
Ikeda, Izumi
Ozoe, Yoshihisa
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1598 - 1600
[43] Differences in binding of epoxymorphinan agonists and antagonists to structural models of the opioid receptor
Strahs, D
Guarnieri, F
Weinstein, H
BIOPHYSICAL JOURNAL, 1997, 72 (02) : WP428 - WP428
[44] Sulfhydryl groups are involved in the binding of agonists and antagonists to the human mineralocorticoid receptor
Souque, A
Fagart, J
Couette, B
RafestinOblin, ME
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 57 (5-6): : 315 - 321
[45] DOPAMINE RECEPTOR-BINDING FOR AGONISTS AND ANTAGONISTS IN THERMAL EXPOSED MEMBRANES
LEW, JY
GOLDSTEIN, M
EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 55 (04) : 429 - 430
[46] OPIATE RECEPTOR-BINDING OF AGONISTS AND ANTAGONISTS AFFECTED DIFFERENTIALLY BY SODIUM
PERT, CB
SNYDER, SH
MOLECULAR PHARMACOLOGY, 1974, 10 (06) : 868 - 879
[47] DIFFERENTIAL RESPONSES TO PURINE RECEPTOR AGONISTS AMONG LYMPHOCYTE POPULATIONS
SAMET, MK
FEDERATION PROCEEDINGS, 1984, 43 (03) : 369 - 369
[48] Muscarinic receptor agonists and antagonists
Zlotos, DP
Bender, W
Holzgrabe, U
EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (08) : 1029 - 1053
[49] Somatostatin receptor agonists and antagonists
Crider, AM
EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (09) : 1427 - 1441
[50] Cannabinoid receptor agonists and antagonists
Barth, F
EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (03) : 301 - 313

← 1 2 3 4 5 →